CRISPR Technology Market Size to Grow by USD 2.88 billion | 44% of the growth to originate from North America | 17,000+ Technavio Reports

For more insights on CAGR and YOY growth variance, Read Our Sample Report

CRISPR Technology Market: Application Landscape

• The CRISPR technology market is segmented by application into biological application, agricultural application, industrial application, and others. The biological application segment held the largest market share in 2021. The segment will continue to account for the highest revenue throughout the forecast period. 
• The growth of the segment is attributed to the increasing number of biomedical research studies being conducted in universities and research institutions. This is due to increasing awareness about the need for multidisciplinary and interdisciplinary genetics research studies to treat complex diseases and disorders has given a boost to biomedical research.

CRISPR Technology Market: Geography Landscape

• 44% of the market's growth will originate from North America during the forecast period. US and Canada are the key markets for CRISPR technology in North America. Market growth in this region will be faster than the growth of the market in Europe and ROW. 
• The increasing spending on research, the presence of biotechnology companies and vendors that offer gene-editing services, and the high focus on biomedical research by universities and research institutions will facilitate the CRISPR technology market growth in North America over the forecast period. 

Download Sample Report for Insights on each contributing segment

CRISPR Technology Market: Vendor Landscape

The CRISPR technology market is fragmented and the vendors are deploying growth strategies such as investment in R&D to compete in the market. To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments. Companies are launching innovative solutions to ensure their position is retained in the market. For instance, Danaher Corp. offers Alt-R CRISPR-Cas9 System, which is an optimized genome editing solution that outperforms other CRISPR approaches for producing on-target, double-stranded DNA breaks.

Companies Covered:

• Addgene Inc.
• Agilent Technologies Inc.
• Applied StemCell Inc.
• Caribou Biosciences Inc.
• Cellecta Inc.
• CRISPR Therapeutics AG
• Danaher Corp.
• Editas Medicine Inc.
• GeneCopoeia Inc.
• GenScript Biotech Corp.
• Intellia Therapeutics Inc.
• Lonza Group Ltd.
• Merck KGaA
• Mirus Bio LLC
• New England Biolabs Inc.
• Novartis AG
• OriGene Technologies Inc.
• PerkinElmer Inc.
• Synthego Corp.
• Thermo Fisher Scientific Inc.

Download Report Sample for more insights on each vendor and their product offerings

What our reports offer:

• Market share assessments for the regional and country-level segments
• Strategic recommendations for the new entrants
• Covers market data for 2020, 2021, until 2026
• Market trends (drivers, opportunities, threats, challenges, investment opportunities, and recommendations)
• Strategic recommendations in key business segments based on the market estimations
• Competitive landscaping mapping the key common trends
• Company profiling with detailed strategies, financials, and recent developments
• Supply chain trends mapping the latest technological advancements

Related Reports:

Seborrheic Keratosis Treatment Market by Application and Geography - Forecast and Analysis 2022-2026

Multiplex Assays Market by Type and Geography - Forecast and Analysis 2022-2026

Table of Content

1 Executive Summary

• 1.1 Market overview
• Exhibit 01: Executive Summary – Chart on Market Overview
• Exhibit 02: Executive Summary – Data Table on Market Overview
• Exhibit 03: Executive Summary – Chart on Global Market Characteristics
• Exhibit 04: Executive Summary – Chart on Market by Geography
• Exhibit 05: Executive Summary – Chart on Market Segmentation by Application
• Exhibit 06: Executive Summary – Chart on Incremental Growth
• Exhibit 07: Executive Summary – Data Table on Incremental Growth
• Exhibit 08: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

• 2.1 Market ecosystem
• Exhibit 09: Parent market
• Exhibit 10: Market Characteristics

3 Market Sizing

• 3.1 Market definition
• Exhibit 11: Offerings of vendors included in the market definition

• 3.2 Market segment analysis
• Exhibit 12: Market segments

• 3.3 Market size 2021

• 3.4 Market outlook: Forecast for 2021-2026
• Exhibit 13: Chart on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 14: Data Table on Global - Market size and forecast 2021-2026 ($ million)
• Exhibit 15: Chart on Global Market: Year-over-year growth 2021-2026 (%)
• Exhibit 16: Data Table on Global Market: Year-over-year growth 2021-2026 (%)

4 Five Forces Analysis

• 4.1 Five forces summary
• Exhibit 17: Five forces analysis - Comparison between 2021 and 2026

• 4.2 Bargaining power of buyers
• Exhibit 18: Chart on Bargaining power of buyers – Impact of key factors 2021 and 2026

• 4.3 Bargaining power of suppliers
• Exhibit 19: Bargaining power of suppliers – Impact of key factors in 2021 and 2026

• 4.4 Threat of new entrants
• Exhibit 20: Threat of new entrants – Impact of key factors in 2021 and 2026

• 4.5 Threat of substitutes
• Exhibit 21: Threat of substitutes – Impact of key factors in 2021 and 2026

• 4.6 Threat of rivalry
• Exhibit 22: Threat of rivalry – Impact of key factors in 2021 and 2026

• 4.7 Market condition
• Exhibit 23: Chart on Market condition - Five forces 2021 and 2026

5 Market Segmentation by Application

• 5.1 Market segments
• Exhibit 24: Chart on Application - Market share 2021-2026 (%)
• Exhibit 25: Data Table on Application - Market share 2021-2026 (%)

• 5.2 Comparison by Application
• Exhibit 26: Chart on Comparison by Application
• Exhibit 27: Data Table on Comparison by Application

• 5.3 Biological application - Market size and forecast 2021-2026
• Exhibit 28: Chart on Biological application - Market size and forecast 2021-2026 ($ million)
• Exhibit 29: Data Table on Biological application - Market size and forecast 2021-2026 ($ million)
• Exhibit 30: Chart on Biological application - Year-over-year growth 2021-2026 (%)
• Exhibit 31: Data Table on Biological application - Year-over-year growth 2021-2026 (%)

• 5.4 Agricultural application - Market size and forecast 2021-2026
• Exhibit 32: Chart on Agricultural application - Market size and forecast 2021-2026 ($ million)
• Exhibit 33: Data Table on Agricultural application - Market size and forecast 2021-2026 ($ million)
• Exhibit 34: Chart on Agricultural application - Year-over-year growth 2021-2026 (%)
• Exhibit 35: Data Table on Agricultural application - Year-over-year growth 2021-2026 (%)

• 5.5 Industrial application - Market size and forecast 2021-2026
• Exhibit 36: Chart on Industrial application - Market size and forecast 2021-2026 ($ million)
• Exhibit 37: Data Table on Industrial application - Market size and forecast 2021-2026 ($ million)
• Exhibit 38: Chart on Industrial application - Year-over-year growth 2021-2026 (%)
• Exhibit 39: Data Table on Industrial application - Year-over-year growth 2021-2026 (%)

• 5.6 Others - Market size and forecast 2021-2026
• Exhibit 40: Chart on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 41: Data Table on Others - Market size and forecast 2021-2026 ($ million)
• Exhibit 42: Chart on Others - Year-over-year growth 2021-2026 (%)
• Exhibit 43: Data Table on Others - Year-over-year growth 2021-2026 (%)

• 5.7 Market opportunity by Application
• Exhibit 44: Market opportunity by Application ($ million)

6 Customer Landscape

• 6.1 Customer landscape overview
• Exhibit 45: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

7 Geographic Landscape

• 7.1 Geographic segmentation
• Exhibit 46: Chart on Market share by geography 2021-2026 (%)
• Exhibit 47: Data Table on Market share by geography 2021-2026 (%)

• 7.2 Geographic comparison
• Exhibit 48: Chart on Geographic comparison
• Exhibit 49: Data Table on Geographic comparison

• 7.3 North America - Market size and forecast 2021-2026
• Exhibit 50: Chart on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 51: Data Table on North America - Market size and forecast 2021-2026 ($ million)
• Exhibit 52: Chart on North America - Year-over-year growth 2021-2026 (%)
• Exhibit 53: Data Table on North America - Year-over-year growth 2021-2026 (%)

• 7.4 Europe - Market size and forecast 2021-2026
• Exhibit 54: Chart on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 55: Data Table on Europe - Market size and forecast 2021-2026 ($ million)
• Exhibit 56: Chart on Europe - Year-over-year growth 2021-2026 (%)
• Exhibit 57: Data Table on Europe - Year-over-year growth 2021-2026 (%)

• 7.5 Asia - Market size and forecast 2021-2026
• Exhibit 58: Chart on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 59: Data Table on Asia - Market size and forecast 2021-2026 ($ million)
• Exhibit 60: Chart on Asia - Year-over-year growth 2021-2026 (%)
• Exhibit 61: Data Table on Asia - Year-over-year growth 2021-2026 (%)

• 7.6 Rest of World (ROW) - Market size and forecast 2021-2026
• Exhibit 62: Chart on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 63: Data Table on Rest of World (ROW) - Market size and forecast 2021-2026 ($ million)
• Exhibit 64: Chart on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)
• Exhibit 65: Data Table on Rest of World (ROW) - Year-over-year growth 2021-2026 (%)

• 7.7 US - Market size and forecast 2021-2026
• Exhibit 66: Chart on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 67: Data Table on US - Market size and forecast 2021-2026 ($ million)
• Exhibit 68: Chart on US - Year-over-year growth 2021-2026 (%)
• Exhibit 69: Data Table on US - Year-over-year growth 2021-2026 (%)

• 7.8 UK - Market size and forecast 2021-2026
• Exhibit 70: Chart on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 71: Data Table on UK - Market size and forecast 2021-2026 ($ million)
• Exhibit 72: Chart on UK - Year-over-year growth 2021-2026 (%)
• Exhibit 73: Data Table on UK - Year-over-year growth 2021-2026 (%)

• 7.9 Canada - Market size and forecast 2021-2026
• Exhibit 74: Chart on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 75: Data Table on Canada - Market size and forecast 2021-2026 ($ million)
• Exhibit 76: Chart on Canada - Year-over-year growth 2021-2026 (%)
• Exhibit 77: Data Table on Canada - Year-over-year growth 2021-2026 (%)

• 7.10 Germany - Market size and forecast 2021-2026
• Exhibit 78: Chart on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 79: Data Table on Germany - Market size and forecast 2021-2026 ($ million)
• Exhibit 80: Chart on Germany - Year-over-year growth 2021-2026 (%)
• Exhibit 81: Data Table on Germany - Year-over-year growth 2021-2026 (%)

• 7.11 Japan - Market size and forecast 2021-2026
• Exhibit 82: Chart on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 83: Data Table on Japan - Market size and forecast 2021-2026 ($ million)
• Exhibit 84: Chart on Japan - Year-over-year growth 2021-2026 (%)
• Exhibit 85: Data Table on Japan - Year-over-year growth 2021-2026 (%)

• 7.12 Market opportunity by geography
• Exhibit 86: Market opportunity by geography ($ million)

8 Drivers, Challenges, and Trends

• 8.1 Market drivers

• 8.2 Market challenges

• 8.3 Impact of drivers and challenges
• Exhibit 87: Impact of drivers and challenges in 2021 and 2026

• 8.4 Market trends

9 Vendor Landscape

• 9.1 Overview

• 9.2 Vendor landscape
• Exhibit 88: Overview on Criticality of inputs and Factors of differentiation

• 9.3 Landscape disruption
• Exhibit 89: Overview on factors of disruption

• 9.4 Industry risks
• Exhibit 90: Impact of key risks on business

10 Vendor Analysis

• 10.1 Vendors covered
• Exhibit 91: Vendors covered

• 10.2 Market positioning of vendors
• Exhibit 92: Matrix on vendor position and classification

• 10.3 Danaher Corp.
• Exhibit 93: Danaher Corp. - Overview
• Exhibit 94: Danaher Corp. - Business segments
• Exhibit 95: Danaher Corp. - Key news
• Exhibit 96: Danaher Corp. - Key offerings
• Exhibit 97: Danaher Corp. - Segment focus

• 10.4 Editas Medicine Inc.
• Exhibit 98: Editas Medicine Inc. - Overview
• Exhibit 99: Editas Medicine Inc. - Product / Service
• Exhibit 100: Editas Medicine Inc. - Key offerings

• 10.5 GeneCopoeia Inc.
• Exhibit 101: GeneCopoeia Inc. - Overview
• Exhibit 102: GeneCopoeia Inc. - Product / Service
• Exhibit 103: GeneCopoeia Inc. - Key offerings

• 10.6 GenScript Biotech Corp.
• Exhibit 104: GenScript Biotech Corp. - Overview
• Exhibit 105: GenScript Biotech Corp. - Business segments
• Exhibit 106: GenScript Biotech Corp. - Key news
• Exhibit 107: GenScript Biotech Corp. - Key offerings
• Exhibit 108: GenScript Biotech Corp. - Segment focus

• 10.7 Intellia Therapeutics Inc.
• Exhibit 109: Intellia Therapeutics Inc. - Overview
• Exhibit 110: Intellia Therapeutics Inc. - Business segments
• Exhibit 111: Intellia Therapeutics Inc. - Key offerings
• Exhibit 112: Intellia Therapeutics Inc. - Segment focus

• 10.8 Lonza Group Ltd.
• Exhibit 113: Lonza Group Ltd. - Overview
• Exhibit 114: Lonza Group Ltd. - Product / Service
• Exhibit 115: Lonza Group Ltd. - Key news
• Exhibit 116: Lonza Group Ltd. - Key offerings

• 10.9 New England Biolabs Inc.
• Exhibit 117: New England Biolabs Inc. - Overview
• Exhibit 118: New England Biolabs Inc. - Product / Service
• Exhibit 119: New England Biolabs Inc. - Key news
• Exhibit 120: New England Biolabs Inc. - Key offerings

• 10.10 OriGene Technologies Inc.
• Exhibit 121: OriGene Technologies Inc. - Overview
• Exhibit 122: OriGene Technologies Inc. - Product / Service
• Exhibit 123: OriGene Technologies Inc. - Key offerings

• 10.11 PerkinElmer Inc.
• Exhibit 124: PerkinElmer Inc. - Overview
• Exhibit 125: PerkinElmer Inc. - Business segments
• Exhibit 126: PerkinElmer Inc. - Key news
• Exhibit 127: PerkinElmer Inc. - Key offerings
• Exhibit 128: PerkinElmer Inc. - Segment focus

• 10.12 Thermo Fisher Scientific Inc.
• Exhibit 129: Thermo Fisher Scientific Inc. - Overview
• Exhibit 130: Thermo Fisher Scientific Inc. - Business segments
• Exhibit 131: Thermo Fisher Scientific Inc. - Key news
• Exhibit 132: Thermo Fisher Scientific Inc. - Key offerings
• Exhibit 133: Thermo Fisher Scientific Inc. - Segment focus

11 Appendix

• 11.1 Scope of the report

• 11.2 Inclusions and exclusions checklist
• Exhibit 134: Inclusions checklist
• Exhibit 135: Exclusions checklist

• 11.3 Currency conversion rates for US$
• Exhibit 136: Currency conversion rates for US$

• 11.4 Research methodology
• Exhibit 137: Research methodology
• Exhibit 138: Validation techniques employed for market sizing
• Exhibit 139: Information sources

• 11.5 List of abbreviations
• Exhibit 140: List of abbreviations

About Us
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.

Contact
Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio